Poster Session I

 

I-1 BMI Acceleration in Early Childhood Has a High Risk for Developing Sustained Obesity Mandy Geserick (Germany)
I-2 Bioactive lipids, inflammation, and coronary artery disease Juliane Dorow (Germany)
I-3 Assessment of homogenous assays for HDL3-Cholesterol, LDL-Triglyceride and Remnant Cholesterol as biomarkers for coronary artery disease Julia Tesar (Germany)
I-4 Association of HDL-Efflux Capacity with Coronary Artery Disease in the LIFE-Heart Study  Lena Bartscher (Germany)
I-5 Reduction of LDL-C levels is most important - Patient Preferences for drug treatment adjunct to LDL-C apheresis in severe hypercholesterolemia Axel Mühlbacher (Germany)
I-7 Heterogeneous preferences in the adjunct drug treatment of severe hypercholesterolemia: A latent-class analysis  Axel Mühlbacher (Germany)
I-8 Apolipoprotein C-II mimetic peptide increases the activity of lipoprotein lipase on remnant lipoproteins in human plasma Mart Reimund (Estonia)
I-9 The cardioprotective potentials of Vernonia calvoana extract in acetaminophen treated male Wistar rats Godwin Egbung (Nigeria)
I-10 Impact of cardiac biomarkers in patients with stable coronary heart disease on the severity of coronary obstruction and survival (LIFE Leipzig Heart Study) Jeffrey Netto (Germany)
I-11 Biomarkers for Mortality Risk Prediction in Cardiogenic Shock Complicating Acute Myocardial Infarction The CULPRIT-SHOCK Biomarker Substudy Pilot

Paul Schellong (Germany)